Regulus Therapeutics Logo Image

Regulus Therapeutics

Regulus Therapeutics Banner Image

Regulus Therapeutics has reached its limit for report views.

Please check back to see if Regulus Therapeutics has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2015 Annual Report and Form 10K

Regulus Therapeutics

Regulus Therapeutics does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Regulus Therapeutics
  • Regulus Therapeutics
  • Regulus Therapeutics

About Regulus Therapeutics

51-200 Employees
Based in San Diego, California

Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field.

Ticker:
RGLS
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol